CINXE.COM
View source for 5α-Reductase inhibitor - Wikipedia
<!DOCTYPE html> <html class="client-nojs vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-clientpref-1 vector-feature-main-menu-pinned-disabled vector-feature-limited-width-clientpref-1 vector-feature-limited-width-content-disabled vector-feature-custom-font-size-clientpref-1 vector-feature-appearance-pinned-clientpref-1 vector-feature-night-mode-enabled skin-theme-clientpref-day vector-toc-not-available" lang="en" dir="ltr"> <head> <meta charset="UTF-8"> <title>View source for 5α-Reductase inhibitor - Wikipedia</title> <script>(function(){var className="client-js vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-clientpref-1 vector-feature-main-menu-pinned-disabled vector-feature-limited-width-clientpref-1 vector-feature-limited-width-content-disabled vector-feature-custom-font-size-clientpref-1 vector-feature-appearance-pinned-clientpref-1 vector-feature-night-mode-enabled skin-theme-clientpref-day vector-toc-not-available";var cookie=document.cookie.match(/(?:^|; )enwikimwclientpreferences=([^;]+)/);if(cookie){cookie[1].split('%2C').forEach(function(pref){className=className.replace(new RegExp('(^| )'+pref.replace(/-clientpref-\w+$|[^\w-]+/g,'')+'-clientpref-\\w+( |$)'),'$1'+pref+'$2');});}document.documentElement.className=className;}());RLCONF={"wgBreakFrames":true,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat": "dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"2d0c94dc-efa9-4673-8bce-fba9cdc2f390","wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"5α-Reductase_inhibitor","wgTitle":"5α-Reductase inhibitor","wgCurRevisionId":1262650612,"wgRevisionId":0,"wgArticleId":1284673,"wgIsArticle":false,"wgIsRedirect":false,"wgAction":"edit","wgUserName":null,"wgUserGroups":["*"],"wgCategories":[],"wgPageViewLanguage":"en","wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"5α-Reductase_inhibitor","wgRelevantArticleId":1284673,"wgIsProbablyEditable":true,"wgRelevantPageIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgNoticeProject":"wikipedia","wgCiteReferencePreviewsActive":false,"wgFlaggedRevsParams":{"tags":{"status":{"levels":1}}},"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true, "wgPopupsFlags":0,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFDisplayWikibaseDescriptions":{"search":true,"watchlist":true,"tagline":false,"nearby":true},"wgWMESchemaEditAttemptStepOversample":false,"wgWMEPageLength":30000,"wgRelatedArticlesCompat":[],"wgEditSubmitButtonLabelPublish":true,"wgULSPosition":"interlanguage","wgULSisCompactLinksEnabled":false,"wgVector2022LanguageInHeader":true,"wgULSisLanguageSelectorEmpty":false,"wgCheckUserClientHintsHeadersJsApi":["brands","architecture","bitness","fullVersionList","mobile","model","platform","platformVersion"],"GEHomepageSuggestedEditsEnableTopics":true,"wgGETopicsMatchModeEnabled":false,"wgGEStructuredTaskRejectionReasonTextInputEnabled":false,"wgGELevelingUpEnabledForUser":false};RLSTATE={"ext.globalCssJs.user.styles":"ready","site.styles":"ready","user.styles":"ready","ext.globalCssJs.user":"ready","user":"ready","user.options":"loading","skins.vector.search.codex.styles": "ready","skins.vector.styles":"ready","skins.vector.icons":"ready","jquery.makeCollapsible.styles":"ready","ext.charinsert.styles":"ready","ext.wikimediamessages.styles":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.uls.interlanguage":"ready","ext.wikimediaBadges":"ready"};RLPAGEMODULES=["mediawiki.action.edit.collapsibleFooter","site","mediawiki.page.ready","jquery.makeCollapsible","skins.vector.js","ext.centralNotice.geoIP","ext.charinsert","ext.gadget.ReferenceTooltips","ext.gadget.charinsert","ext.gadget.extra-toolbar-buttons","ext.gadget.refToolbar","ext.gadget.switcher","ext.urlShortener.toolbar","ext.centralauth.centralautologin","mmv.bootstrap","ext.popups","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.echo.centralauth","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","ext.uls.interface","ext.cx.eventlogging.campaigns","ext.checkUser.clientHints","ext.growthExperiments.SuggestedEditSession"];</script> <script>(RLQ=window.RLQ||[]).push(function(){mw.loader.impl(function(){return["user.options@12s5i",function($,jQuery,require,module){mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"}); }];});});</script> <link rel="stylesheet" href="/w/load.php?lang=en&modules=ext.charinsert.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cext.wikimediamessages.styles%7Cjquery.makeCollapsible.styles%7Cskins.vector.icons%2Cstyles%7Cskins.vector.search.codex.styles&only=styles&skin=vector-2022"> <script async="" src="/w/load.php?lang=en&modules=startup&only=scripts&raw=1&skin=vector-2022"></script> <meta name="ResourceLoaderDynamicStyles" content=""> <link rel="stylesheet" href="/w/load.php?lang=en&modules=site.styles&only=styles&skin=vector-2022"> <meta name="generator" content="MediaWiki 1.44.0-wmf.6"> <meta name="referrer" content="origin"> <meta name="referrer" content="origin-when-cross-origin"> <meta name="robots" content="noindex,nofollow,max-image-preview:standard"> <meta name="format-detection" content="telephone=no"> <meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/2/21/Dutasteride.svg/1200px-Dutasteride.svg.png"> <meta property="og:image:width" content="1200"> <meta property="og:image:height" content="1111"> <meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/2/21/Dutasteride.svg/800px-Dutasteride.svg.png"> <meta property="og:image:width" content="800"> <meta property="og:image:height" content="741"> <meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/2/21/Dutasteride.svg/640px-Dutasteride.svg.png"> <meta property="og:image:width" content="640"> <meta property="og:image:height" content="593"> <meta name="viewport" content="width=1120"> <meta property="og:title" content="View source for 5α-Reductase inhibitor - Wikipedia"> <meta property="og:type" content="website"> <link rel="preconnect" href="//upload.wikimedia.org"> <link rel="alternate" media="only screen and (max-width: 640px)" href="//en.m.wikipedia.org/wiki/5%CE%B1-Reductase_inhibitor"> <link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=edit"> <link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"> <link rel="icon" href="/static/favicon/wikipedia.ico"> <link rel="search" type="application/opensearchdescription+xml" href="/w/rest.php/v1/search" title="Wikipedia (en)"> <link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"> <link rel="canonical" href="https://en.wikipedia.org/wiki/5%CE%B1-Reductase_inhibitor"> <link rel="license" href="https://creativecommons.org/licenses/by-sa/4.0/deed.en"> <link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&feed=atom"> <link rel="dns-prefetch" href="login.wikimedia.org"> </head> <body class="skin--responsive skin-vector skin-vector-search-vue mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-5α-Reductase_inhibitor rootpage-5α-Reductase_inhibitor skin-vector-2022 action-edit"><a class="mw-jump-link" href="#bodyContent">Jump to content</a> <div class="vector-header-container"> <header class="vector-header mw-header"> <div class="vector-header-start"> <nav class="vector-main-menu-landmark" aria-label="Site"> <div id="vector-main-menu-dropdown" class="vector-dropdown vector-main-menu-dropdown vector-button-flush-left vector-button-flush-right" > <input type="checkbox" id="vector-main-menu-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-main-menu-dropdown" class="vector-dropdown-checkbox " aria-label="Main menu" > <label id="vector-main-menu-dropdown-label" for="vector-main-menu-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" ><span class="vector-icon mw-ui-icon-menu mw-ui-icon-wikimedia-menu"></span> <span class="vector-dropdown-label-text">Main menu</span> </label> <div class="vector-dropdown-content"> <div id="vector-main-menu-unpinned-container" class="vector-unpinned-container"> <div id="vector-main-menu" class="vector-main-menu vector-pinnable-element"> <div class="vector-pinnable-header vector-main-menu-pinnable-header vector-pinnable-header-unpinned" data-feature-name="main-menu-pinned" data-pinnable-element-id="vector-main-menu" data-pinned-container-id="vector-main-menu-pinned-container" data-unpinned-container-id="vector-main-menu-unpinned-container" > <div class="vector-pinnable-header-label">Main menu</div> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-main-menu.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-main-menu.unpin">hide</button> </div> <div id="p-navigation" class="vector-menu mw-portlet mw-portlet-navigation" > <div class="vector-menu-heading"> Navigation </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="n-mainpage-description" class="mw-list-item"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"><span>Main page</span></a></li><li id="n-contents" class="mw-list-item"><a href="/wiki/Wikipedia:Contents" title="Guides to browsing Wikipedia"><span>Contents</span></a></li><li id="n-currentevents" class="mw-list-item"><a href="/wiki/Portal:Current_events" title="Articles related to current events"><span>Current events</span></a></li><li id="n-randompage" class="mw-list-item"><a href="/wiki/Special:Random" title="Visit a randomly selected article [x]" accesskey="x"><span>Random article</span></a></li><li id="n-aboutsite" class="mw-list-item"><a href="/wiki/Wikipedia:About" title="Learn about Wikipedia and how it works"><span>About Wikipedia</span></a></li><li id="n-contactpage" class="mw-list-item"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia"><span>Contact us</span></a></li> </ul> </div> </div> <div id="p-interaction" class="vector-menu mw-portlet mw-portlet-interaction" > <div class="vector-menu-heading"> Contribute </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="n-help" class="mw-list-item"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia"><span>Help</span></a></li><li id="n-introduction" class="mw-list-item"><a href="/wiki/Help:Introduction" title="Learn how to edit Wikipedia"><span>Learn to edit</span></a></li><li id="n-portal" class="mw-list-item"><a href="/wiki/Wikipedia:Community_portal" title="The hub for editors"><span>Community portal</span></a></li><li id="n-recentchanges" class="mw-list-item"><a href="/wiki/Special:RecentChanges" title="A list of recent changes to Wikipedia [r]" accesskey="r"><span>Recent changes</span></a></li><li id="n-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_upload_wizard" title="Add images or other media for use on Wikipedia"><span>Upload file</span></a></li> </ul> </div> </div> </div> </div> </div> </div> </nav> <a href="/wiki/Main_Page" class="mw-logo"> <img class="mw-logo-icon" src="/static/images/icons/wikipedia.png" alt="" aria-hidden="true" height="50" width="50"> <span class="mw-logo-container skin-invert"> <img class="mw-logo-wordmark" alt="Wikipedia" src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" style="width: 7.5em; height: 1.125em;"> <img class="mw-logo-tagline" alt="The Free Encyclopedia" src="/static/images/mobile/copyright/wikipedia-tagline-en.svg" width="117" height="13" style="width: 7.3125em; height: 0.8125em;"> </span> </a> </div> <div class="vector-header-end"> <div id="p-search" role="search" class="vector-search-box-vue vector-search-box-collapses vector-search-box-show-thumbnail vector-search-box-auto-expand-width vector-search-box"> <a href="/wiki/Special:Search" class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only search-toggle" title="Search Wikipedia [f]" accesskey="f"><span class="vector-icon mw-ui-icon-search mw-ui-icon-wikimedia-search"></span> <span>Search</span> </a> <div class="vector-typeahead-search-container"> <div class="cdx-typeahead-search cdx-typeahead-search--show-thumbnail cdx-typeahead-search--auto-expand-width"> <form action="/w/index.php" id="searchform" class="cdx-search-input cdx-search-input--has-end-button"> <div id="simpleSearch" class="cdx-search-input__input-wrapper" data-search-loc="header-moved"> <div class="cdx-text-input cdx-text-input--has-start-icon"> <input class="cdx-text-input__input" type="search" name="search" placeholder="Search Wikipedia" aria-label="Search Wikipedia" autocapitalize="sentences" title="Search Wikipedia [f]" accesskey="f" id="searchInput" > <span class="cdx-text-input__icon cdx-text-input__start-icon"></span> </div> <input type="hidden" name="title" value="Special:Search"> </div> <button class="cdx-button cdx-search-input__end-button">Search</button> </form> </div> </div> </div> <nav class="vector-user-links vector-user-links-wide" aria-label="Personal tools"> <div class="vector-user-links-main"> <div id="p-vector-user-menu-preferences" class="vector-menu mw-portlet emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> <div id="p-vector-user-menu-userpage" class="vector-menu mw-portlet emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> <nav class="vector-appearance-landmark" aria-label="Appearance"> <div id="vector-appearance-dropdown" class="vector-dropdown " title="Change the appearance of the page's font size, width, and color" > <input type="checkbox" id="vector-appearance-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-appearance-dropdown" class="vector-dropdown-checkbox " aria-label="Appearance" > <label id="vector-appearance-dropdown-label" for="vector-appearance-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" ><span class="vector-icon mw-ui-icon-appearance mw-ui-icon-wikimedia-appearance"></span> <span class="vector-dropdown-label-text">Appearance</span> </label> <div class="vector-dropdown-content"> <div id="vector-appearance-unpinned-container" class="vector-unpinned-container"> </div> </div> </div> </nav> <div id="p-vector-user-menu-notifications" class="vector-menu mw-portlet emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> <div id="p-vector-user-menu-overflow" class="vector-menu mw-portlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="pt-sitesupport-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="https://donate.wikimedia.org/?wmf_source=donate&wmf_medium=sidebar&wmf_campaign=en.wikipedia.org&uselang=en" class=""><span>Donate</span></a> </li> <li id="pt-createaccount-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="/w/index.php?title=Special:CreateAccount&returnto=5%CE%B1-Reductase+inhibitor&returntoquery=action%3Dedit" title="You are encouraged to create an account and log in; however, it is not mandatory" class=""><span>Create account</span></a> </li> <li id="pt-login-2" class="user-links-collapsible-item mw-list-item user-links-collapsible-item"><a data-mw="interface" href="/w/index.php?title=Special:UserLogin&returnto=5%CE%B1-Reductase+inhibitor&returntoquery=action%3Dedit" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o" class=""><span>Log in</span></a> </li> </ul> </div> </div> </div> <div id="vector-user-links-dropdown" class="vector-dropdown vector-user-menu vector-button-flush-right vector-user-menu-logged-out" title="Log in and more options" > <input type="checkbox" id="vector-user-links-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-user-links-dropdown" class="vector-dropdown-checkbox " aria-label="Personal tools" > <label id="vector-user-links-dropdown-label" for="vector-user-links-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only " aria-hidden="true" ><span class="vector-icon mw-ui-icon-ellipsis mw-ui-icon-wikimedia-ellipsis"></span> <span class="vector-dropdown-label-text">Personal tools</span> </label> <div class="vector-dropdown-content"> <div id="p-personal" class="vector-menu mw-portlet mw-portlet-personal user-links-collapsible-item" title="User menu" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="pt-sitesupport" class="user-links-collapsible-item mw-list-item"><a href="https://donate.wikimedia.org/?wmf_source=donate&wmf_medium=sidebar&wmf_campaign=en.wikipedia.org&uselang=en"><span>Donate</span></a></li><li id="pt-createaccount" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:CreateAccount&returnto=5%CE%B1-Reductase+inhibitor&returntoquery=action%3Dedit" title="You are encouraged to create an account and log in; however, it is not mandatory"><span class="vector-icon mw-ui-icon-userAdd mw-ui-icon-wikimedia-userAdd"></span> <span>Create account</span></a></li><li id="pt-login" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:UserLogin&returnto=5%CE%B1-Reductase+inhibitor&returntoquery=action%3Dedit" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o"><span class="vector-icon mw-ui-icon-logIn mw-ui-icon-wikimedia-logIn"></span> <span>Log in</span></a></li> </ul> </div> </div> <div id="p-user-menu-anon-editor" class="vector-menu mw-portlet mw-portlet-user-menu-anon-editor" > <div class="vector-menu-heading"> Pages for logged out editors <a href="/wiki/Help:Introduction" aria-label="Learn more about editing"><span>learn more</span></a> </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="pt-anoncontribs" class="mw-list-item"><a href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]" accesskey="y"><span>Contributions</span></a></li><li id="pt-anontalk" class="mw-list-item"><a href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]" accesskey="n"><span>Talk</span></a></li> </ul> </div> </div> </div> </div> </nav> </div> </header> </div> <div class="mw-page-container"> <div class="mw-page-container-inner"> <div class="vector-sitenotice-container"> <div id="siteNotice"><!-- CentralNotice --></div> </div> <div class="vector-column-start"> <div class="vector-main-menu-container"> <div id="mw-navigation"> <nav id="mw-panel" class="vector-main-menu-landmark" aria-label="Site"> <div id="vector-main-menu-pinned-container" class="vector-pinned-container"> </div> </nav> </div> </div> </div> <div class="mw-content-container"> <main id="content" class="mw-body"> <header class="mw-body-header vector-page-titlebar"> <h1 id="firstHeading" class="firstHeading mw-first-heading">View source for 5α-Reductase inhibitor</h1> <div id="p-lang-btn" class="vector-dropdown mw-portlet mw-portlet-lang" > <input type="checkbox" id="p-lang-btn-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-p-lang-btn" class="vector-dropdown-checkbox mw-interlanguage-selector" aria-label="This article exist only in this language. Add the article for other languages" > <label id="p-lang-btn-label" for="p-lang-btn-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--action-progressive mw-portlet-lang-heading-0" aria-hidden="true" ><span class="vector-icon mw-ui-icon-language-progressive mw-ui-icon-wikimedia-language-progressive"></span> <span class="vector-dropdown-label-text">Add languages</span> </label> <div class="vector-dropdown-content"> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> <div class="after-portlet after-portlet-lang"><span class="uls-after-portlet-link"></span></div> </div> </div> </div> </header> <div class="vector-page-toolbar"> <div class="vector-page-toolbar-container"> <div id="left-navigation"> <nav aria-label="Namespaces"> <div id="p-associated-pages" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-associated-pages" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="ca-nstab-main" class="selected vector-tab-noicon mw-list-item"><a href="/wiki/5%CE%B1-Reductase_inhibitor" title="View the content page [c]" accesskey="c"><span>Article</span></a></li><li id="ca-talk" class="vector-tab-noicon mw-list-item"><a href="/wiki/Talk:5%CE%B1-Reductase_inhibitor" rel="discussion" title="Discuss improvements to the content page [t]" accesskey="t"><span>Talk</span></a></li> </ul> </div> </div> <div id="vector-variants-dropdown" class="vector-dropdown emptyPortlet" > <input type="checkbox" id="vector-variants-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-variants-dropdown" class="vector-dropdown-checkbox " aria-label="Change language variant" > <label id="vector-variants-dropdown-label" for="vector-variants-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet" aria-hidden="true" ><span class="vector-dropdown-label-text">English</span> </label> <div class="vector-dropdown-content"> <div id="p-variants" class="vector-menu mw-portlet mw-portlet-variants emptyPortlet" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> </ul> </div> </div> </div> </div> </nav> </div> <div id="right-navigation" class="vector-collapsible"> <nav aria-label="Views"> <div id="p-views" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-views" > <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="ca-view" class="vector-tab-noicon mw-list-item"><a href="/wiki/5%CE%B1-Reductase_inhibitor"><span>Read</span></a></li><li id="ca-edit" class="selected vector-tab-noicon mw-list-item"><a href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=edit" title="Edit this page"><span>Edit</span></a></li><li id="ca-history" class="vector-tab-noicon mw-list-item"><a href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=history" title="Past revisions of this page [h]" accesskey="h"><span>View history</span></a></li> </ul> </div> </div> </nav> <nav class="vector-page-tools-landmark" aria-label="Page tools"> <div id="vector-page-tools-dropdown" class="vector-dropdown vector-page-tools-dropdown" > <input type="checkbox" id="vector-page-tools-dropdown-checkbox" role="button" aria-haspopup="true" data-event-name="ui.dropdown-vector-page-tools-dropdown" class="vector-dropdown-checkbox " aria-label="Tools" > <label id="vector-page-tools-dropdown-label" for="vector-page-tools-dropdown-checkbox" class="vector-dropdown-label cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet" aria-hidden="true" ><span class="vector-dropdown-label-text">Tools</span> </label> <div class="vector-dropdown-content"> <div id="vector-page-tools-unpinned-container" class="vector-unpinned-container"> <div id="vector-page-tools" class="vector-page-tools vector-pinnable-element"> <div class="vector-pinnable-header vector-page-tools-pinnable-header vector-pinnable-header-unpinned" data-feature-name="page-tools-pinned" data-pinnable-element-id="vector-page-tools" data-pinned-container-id="vector-page-tools-pinned-container" data-unpinned-container-id="vector-page-tools-unpinned-container" > <div class="vector-pinnable-header-label">Tools</div> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-page-tools.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-page-tools.unpin">hide</button> </div> <div id="p-cactions" class="vector-menu mw-portlet mw-portlet-cactions emptyPortlet vector-has-collapsible-items" title="More options" > <div class="vector-menu-heading"> Actions </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="ca-more-view" class="vector-more-collapsible-item mw-list-item"><a href="/wiki/5%CE%B1-Reductase_inhibitor"><span>Read</span></a></li><li id="ca-more-edit" class="selected vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=edit" title="Edit this page [e]" accesskey="e"><span>Edit</span></a></li><li id="ca-more-history" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=history"><span>View history</span></a></li> </ul> </div> </div> <div id="p-tb" class="vector-menu mw-portlet mw-portlet-tb" > <div class="vector-menu-heading"> General </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="t-whatlinkshere" class="mw-list-item"><a href="/wiki/Special:WhatLinksHere/5%CE%B1-Reductase_inhibitor" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j"><span>What links here</span></a></li><li id="t-recentchangeslinked" class="mw-list-item"><a href="/wiki/Special:RecentChangesLinked/5%CE%B1-Reductase_inhibitor" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k"><span>Related changes</span></a></li><li id="t-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u"><span>Upload file</span></a></li><li id="t-specialpages" class="mw-list-item"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q"><span>Special pages</span></a></li><li id="t-info" class="mw-list-item"><a href="/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=info" title="More information about this page"><span>Page information</span></a></li><li id="t-urlshortener" class="mw-list-item"><a href="/w/index.php?title=Special:UrlQ%C4%B1sald%C4%B1c%C4%B1s%C4%B1&url=https%3A%2F%2Fen.wikipedia.org%2Fw%2Findex.php%3Ftitle%3D5%25CE%25B1-Reductase_inhibitor%26action%3Dedit"><span>Get shortened URL</span></a></li><li id="t-urlshortener-qrcode" class="mw-list-item"><a href="/w/index.php?title=Special:QrKodu&url=https%3A%2F%2Fen.wikipedia.org%2Fw%2Findex.php%3Ftitle%3D5%25CE%25B1-Reductase_inhibitor%26action%3Dedit"><span>Download QR code</span></a></li> </ul> </div> </div> <div id="p-wikibase-otherprojects" class="vector-menu mw-portlet mw-portlet-wikibase-otherprojects" > <div class="vector-menu-heading"> In other projects </div> <div class="vector-menu-content"> <ul class="vector-menu-content-list"> <li id="t-wikibase" class="wb-otherproject-link wb-otherproject-wikibase-dataitem mw-list-item"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q4639645" title="Structured data on this page hosted by Wikidata [g]" accesskey="g"><span>Wikidata item</span></a></li> </ul> </div> </div> </div> </div> </div> </div> </nav> </div> </div> </div> <div class="vector-column-end"> <div class="vector-sticky-pinned-container"> <nav class="vector-page-tools-landmark" aria-label="Page tools"> <div id="vector-page-tools-pinned-container" class="vector-pinned-container"> </div> </nav> <nav class="vector-appearance-landmark" aria-label="Appearance"> <div id="vector-appearance-pinned-container" class="vector-pinned-container"> <div id="vector-appearance" class="vector-appearance vector-pinnable-element"> <div class="vector-pinnable-header vector-appearance-pinnable-header vector-pinnable-header-pinned" data-feature-name="appearance-pinned" data-pinnable-element-id="vector-appearance" data-pinned-container-id="vector-appearance-pinned-container" data-unpinned-container-id="vector-appearance-unpinned-container" > <div class="vector-pinnable-header-label">Appearance</div> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-appearance.pin">move to sidebar</button> <button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-appearance.unpin">hide</button> </div> </div> </div> </nav> </div> </div> <div id="bodyContent" class="vector-body" aria-labelledby="firstHeading" data-mw-ve-target-container> <div class="vector-body-before-content"> <div class="mw-indicators"> </div> </div> <div id="contentSub"><div id="mw-content-subtitle">← <a href="/wiki/5%CE%B1-Reductase_inhibitor" title="5α-Reductase inhibitor">5α-Reductase inhibitor</a></div></div> <div id="mw-content-text" class="mw-body-content"><p>You do not have permission to edit this page, for the following reasons: </p> <ul class="permissions-errors"><li class="mw-permissionerror-blockedtext"> <div id="mw-blocked-text" style="border: 1px solid #AAA; background-color: var(--background-color-warning-subtle, ivory); color: inherit; padding: 1.5em; width: 100%; box-sizing: border-box;"> <div style="text-align: center;"><span style="font-size: 26px;"><span typeof="mw:File"><a href="/wiki/File:Stop_hand_nuvola.svg" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/en/thumb/f/f1/Stop_hand_nuvola.svg/50px-Stop_hand_nuvola.svg.png" decoding="async" width="50" height="50" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/f1/Stop_hand_nuvola.svg/75px-Stop_hand_nuvola.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/f1/Stop_hand_nuvola.svg/100px-Stop_hand_nuvola.svg.png 2x" data-file-width="240" data-file-height="240" /></a></span><b> This IP address has been <a href="/wiki/Wikipedia:Blocking_policy" title="Wikipedia:Blocking policy">blocked</a> from <i>editing</i> Wikipedia.</b></span><br /><span style="font-size: 18px;">This does not affect your ability to <i>read</i> Wikipedia pages.</span></div><div class="paragraphbreak" style="margin-top:0.5em"></div><b>Most people who see this message have done nothing wrong.</b> Some kinds of blocks restrict editing from specific service providers or telecom companies in response to recent abuse or vandalism, and can sometimes affect other users who are unrelated to that abuse. Review the information below for assistance if you do not believe that you have done anything wrong.<div class="paragraphbreak" style="margin-top:0.5em"></div> <p>The IP address or range 8.222.128.0/17 has been <a href="/wiki/Wikipedia:Blocking_policy" title="Wikipedia:Blocking policy">blocked</a> by <a href="/wiki/User:L235" title="User:L235">L235</a> for the following reason(s): </p> <div style="padding:10px; background:var(--background-color-base, white); color:inherit; border:1px #666 solid;"> <div class="user-block colocation-webhost" style="margin-bottom: 0.5em; background-color: #ffefd5; border: 1px solid #AAA; padding: 0.7em;"> <figure class="mw-halign-left" typeof="mw:File"><span><img src="//upload.wikimedia.org/wikipedia/commons/thumb/5/53/Server-multiple.svg/40px-Server-multiple.svg.png" decoding="async" width="40" height="57" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/53/Server-multiple.svg/60px-Server-multiple.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/53/Server-multiple.svg/80px-Server-multiple.svg.png 2x" data-file-width="744" data-file-height="1052" /></span><figcaption></figcaption></figure><b>The <a href="/wiki/IP_address" title="IP address">IP address</a> that you are currently using has been blocked because it is believed to be a <a href="/wiki/Web_hosting_service" title="Web hosting service">web host provider</a> or <a href="/wiki/Colocation_centre" title="Colocation centre">colocation provider</a>.</b> To prevent abuse, <a href="/wiki/Wikipedia:Open_proxies" title="Wikipedia:Open proxies">web hosts and colocation providers may be blocked</a> from editing Wikipedia. <div style="border-top: 1px solid #AAA; clear: both">You will not be able to edit Wikipedia using a web host or colocation provider because it hides your IP address, much like a <a href="/wiki/Wikipedia:Open_proxies" title="Wikipedia:Open proxies">proxy</a> or <a href="/wiki/Virtual_private_network" title="Virtual private network">VPN</a>. <p><b>We recommend that you attempt to use another connection to edit.</b> For example, if you use a proxy or VPN to connect to the internet, turn it off when editing Wikipedia. If you edit using a mobile connection, try using a Wi-Fi connection, and vice versa. If you are using a corporate internet connection, switch to a different Wi-Fi network. If you have a Wikipedia account, please log in. </p><p>If you do not have any other way to edit Wikipedia, you will need to <a href="/wiki/Wikipedia:IP_block_exemption#Requesting_and_granting_exemption" title="Wikipedia:IP block exemption">request an IP block exemption</a>. </p> <style data-mw-deduplicate="TemplateStyles:r1214851843">.mw-parser-output .hidden-begin{box-sizing:border-box;width:100%;padding:5px;border:none;font-size:95%}.mw-parser-output .hidden-title{font-weight:bold;line-height:1.6;text-align:left}.mw-parser-output .hidden-content{text-align:left}@media all and (max-width:500px){.mw-parser-output .hidden-begin{width:auto!important;clear:none!important;float:none!important}}</style><div class="hidden-begin mw-collapsible mw-collapsed" style=""><div class="hidden-title skin-nightmode-reset-color" style="text-align:center;">How to appeal if you are confident that your connection does not use a colocation provider's IP address:</div><div class="hidden-content mw-collapsible-content" style=""> If you are confident that you are not using a web host, you may <a href="/wiki/Wikipedia:Appealing_a_block" title="Wikipedia:Appealing a block">appeal this block</a> by adding the following text on your <a href="/wiki/Help:Talk_pages" title="Help:Talk pages">talk page</a>: <code>{{<a href="/wiki/Template:Unblock" title="Template:Unblock">unblock</a>|reason=Caught by a colocation web host block but this host or IP is not a web host. My IP address is _______. <i>Place any further information here.</i> ~~~~}}</code>. <b>You must fill in the blank with your IP address for this block to be investigated.</b> Your IP address can be determined <span class="plainlinks"><b><a class="external text" href="https://en.wikipedia.org/wiki/Wikipedia:Get_my_IP_address?withJS=MediaWiki:Get-my-ip.js">here</a></b></span>. Alternatively, if you wish to keep your IP address private you can use the <a href="/wiki/Wikipedia:Unblock_Ticket_Request_System" title="Wikipedia:Unblock Ticket Request System">unblock ticket request system</a>. There are several reasons you might be editing using the IP address of a web host or colocation provider (such as if you are using VPN software or a business network); please use this method of appeal only if you think your IP address is in fact not a web host or colocation provider.</div></div> <p><span class="sysop-show" style="font-size: 85%;"><span style="border:#707070 solid 1px;background-color:#ffe0e0;padding:2px"><b>Administrators:</b></span> The <a href="/wiki/Wikipedia:IP_block_exemption" title="Wikipedia:IP block exemption">IP block exemption</a> user right should only be applied to allow users to edit using web host in exceptional circumstances, and requests should usually be directed to the functionaries team via email. If you intend to give the IPBE user right, a <a href="/wiki/Wikipedia:CheckUser" title="Wikipedia:CheckUser">CheckUser</a> needs to take a look at the account. This can be requested most easily at <a href="/wiki/Wikipedia:SPI#Quick_CheckUser_requests" class="mw-redirect" title="Wikipedia:SPI">SPI Quick Checkuser Requests</a>. <b>Unblocking</b> an IP or IP range with this template <b>is highly discouraged</b> without at least contacting the blocking administrator.</span> </p> </div></div> </div> <p>This block will expire on 18:23, 24 August 2026. Your current IP address is 8.222.208.146. </p> <div class="paragraphbreak" style="margin-top:0.5em"></div><div style="font-size: 16px;"> <p>Even when blocked, you will <i>usually</i> still be able to edit your <a href="/wiki/Special:MyTalk" title="Special:MyTalk">user talk page</a>, as well as <a href="/wiki/Wikipedia:Emailing_users" title="Wikipedia:Emailing users">email</a> administrators and other editors. </p> </div> <div class="paragraphbreak" style="margin-top:0.5em"></div><div style="font-size: 16px;"> <p>For information on how to proceed, please read the <b><a href="/wiki/Wikipedia:Appealing_a_block#Common_questions" title="Wikipedia:Appealing a block">FAQ for blocked users</a></b> and the <a href="/wiki/Wikipedia:Appealing_a_block" title="Wikipedia:Appealing a block">guideline on block appeals</a>. The <a href="/wiki/Wikipedia:Guide_to_appealing_blocks" title="Wikipedia:Guide to appealing blocks">guide to appealing blocks</a> may also be helpful. </p> </div> <p>Other useful links: <a href="/wiki/Wikipedia:Blocking_policy" title="Wikipedia:Blocking policy">Blocking policy</a> · <a href="/wiki/Help:I_have_been_blocked" title="Help:I have been blocked">Help:I have been blocked</a> </p> </div></li><li class="mw-permissionerror-globalblocking-blockedtext-range"> <div id="mw-blocked-text" style="border: 1px solid #AAA; background-color: var(--background-color-warning-subtle, ivory); color: inherit; padding: 1.5em; width: 100%; box-sizing: border-box;"> <div style="text-align: center;"><span style="font-size: 26px;"><span typeof="mw:File"><a href="/wiki/File:Stop_hand_nuvola.svg" class="mw-file-description"><img src="//upload.wikimedia.org/wikipedia/en/thumb/f/f1/Stop_hand_nuvola.svg/50px-Stop_hand_nuvola.svg.png" decoding="async" width="50" height="50" class="mw-file-element" srcset="//upload.wikimedia.org/wikipedia/en/thumb/f/f1/Stop_hand_nuvola.svg/75px-Stop_hand_nuvola.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/f1/Stop_hand_nuvola.svg/100px-Stop_hand_nuvola.svg.png 2x" data-file-width="240" data-file-height="240" /></a></span><b> This IP address range has been <a href="https://meta.wikimedia.org/wiki/Global_blocks" class="extiw" title="m:Global blocks">globally blocked</a>.</b></span><br /><span style="font-size: 18px;">This does not affect your ability to <i>read</i> Wikipedia pages.</span></div><div class="paragraphbreak" style="margin-top:0.5em"></div><b>Most people who see this message have done nothing wrong.</b> Some kinds of blocks restrict editing from specific service providers or telecom companies in response to recent abuse or vandalism, and can sometimes affect other users who are unrelated to that abuse. Review the information below for assistance if you do not believe that you have done anything wrong.<div class="paragraphbreak" style="margin-top:0.5em"></div><div class="paragraphbreak" style="margin-top:0.5em"></div> <p>This block affects editing on all Wikimedia wikis. </p><p>The IP address or range 8.222.128.0/17 has been globally <a href="/wiki/Wikipedia:Blocking_policy" title="Wikipedia:Blocking policy">blocked</a> by <a href="/wiki/User:Jon_Kolbert" title="User:Jon Kolbert">Jon Kolbert</a> for the following reason(s): </p> <div style="padding:10px; background:var(--background-color-base, white); color:inherit; border:1px #666 solid;"> <p><a href="https://meta.wikimedia.org/wiki/Special:MyLanguage/NOP" class="extiw" title="m:Special:MyLanguage/NOP">Open proxy/Webhost</a>: See the <a href="https://meta.wikimedia.org/wiki/WM:OP/H" class="extiw" title="m:WM:OP/H">help page</a> if you are affected </p> </div> <p>This block will expire on 15:12, 27 August 2028. Your current IP address is 8.222.208.146. </p> <div class="paragraphbreak" style="margin-top:0.5em"></div><div style="font-size: 16px;"> <p>Even while globally blocked, you will <i>usually</i> still be able to edit pages on <a href="https://meta.wikimedia.org/wiki/" class="extiw" title="m:">Meta-Wiki</a>. </p> </div> <div class="paragraphbreak" style="margin-top:0.5em"></div><div style="font-size: 16px;"> <p>If you believe you were blocked by mistake, you can find additional information and instructions in the <a href="https://meta.wikimedia.org/wiki/Special:MyLanguage/No_open_proxies" class="extiw" title="m:Special:MyLanguage/No open proxies">No open proxies</a> global policy. Otherwise, to discuss the block please <a href="https://meta.wikimedia.org/wiki/Steward_requests/Global" class="extiw" title="m:Steward requests/Global">post a request for review on Meta-Wiki</a>. You could also send an email to the <a href="https://meta.wikimedia.org/wiki/Special:MyLanguage/Stewards" class="extiw" title="m:Special:MyLanguage/Stewards">stewards</a> <a href="https://meta.wikimedia.org/wiki/Special:MyLanguage/VRT" class="extiw" title="m:Special:MyLanguage/VRT">VRT</a> queue at <kbd>stewards@wikimedia.org</kbd> including all above details. </p> </div> <p>Other useful links: <a href="https://meta.wikimedia.org/wiki/Global_blocks" class="extiw" title="m:Global blocks">Global blocks</a> · <a href="/wiki/Help:I_have_been_blocked" title="Help:I have been blocked">Help:I have been blocked</a> </p> </div></li></ul><hr /> <div id="viewsourcetext">You can view and copy the source of this page:</div><textarea readonly="" accesskey="," id="wpTextbox1" cols="80" rows="25" style="" class="mw-editfont-monospace" lang="en" dir="ltr" name="wpTextbox1">{{Short description|Class of medications}} {{Infobox drug class | Image = Dutasteride.svg | ImageClass = skin-invert-image | Alt = | Caption = [[Dutasteride]], one of the most widely used 5α-reductase inhibitors. | Width = 250px | Synonyms = Dihydrotestosterone blockers; DHT blockers <!-- Class identifiers --> | Use = [[Benign prostatic hyperplasia]], [[pattern hair loss]], [[hirsutism]], [[Feminizing hormone therapy|feminizing HRT]] | ATC_prefix = G04CB | Biological_target = [[5α-Reductase]] ([[SRD5A1|1]], [[SRD5A2|2]], [[SRD5A3|3]]) | Chemical_class = [[Steroid]]s; [[Azasteroid]]s <!-- Clinical data --> | Drugs.com = | Consumer_Reports = | medicinenet = | rxlist = <!-- External links --> | MeshID = }} '''5α-Reductase inhibitors''' ('''5-ARIs'''), also known as '''dihydrotestosterone''' ('''DHT''') '''blockers''', are a class of [[medication]]s with [[antiandrogen]]ic effects which are used primarily in the treatment of [[benign prostatic hyperplasia|enlarged prostate]] and [[pattern hair loss|scalp hair loss]]. They are also sometimes used to treat [[hirsutism|excess hair growth]] in women and as a component of [[feminizing hormone therapy|hormone therapy]] for [[transgender women]].<ref name="Blume-PeytaviWhiting2008">{{cite book|author1=Ulrike Blume-Peytavi|author2=David A. Whiting|author3=Ralph M. Trüeb|title=Hair Growth and Disorders|url=https://books.google.com/books?id=pHrX2-huQCoC&pg=PA368|date=26 June 2008|publisher=Springer Science & Business Media|isbn=978-3-540-46911-7|pages=368–370|access-date=29 October 2016|archive-date=9 November 2023|archive-url=https://web.archive.org/web/20231109232624/https://books.google.com/books?id=pHrX2-huQCoC&pg=PA368#v=onepage&q&f=false|url-status=live}}</ref><ref name="pmid28159148">{{cite journal | vauthors = Wesp LM, Deutsch MB | title = Hormonal and Surgical Treatment Options for Transgender Women and Transfeminine Spectrum Persons | journal = Psychiatr. Clin. North Am. | volume = 40 | issue = 1 | pages = 99–111 | year = 2017 | pmid = 28159148 | doi = 10.1016/j.psc.2016.10.006 }}</ref> These agents inhibit the [[enzyme]] [[5α-reductase]], which is involved in the [[metabolic transformation]]s of a variety of [[endogenous]] [[steroid]]s. 5-ARIs are most known for preventing conversion of [[testosterone]], the major [[androgen]] [[sex hormone]], to the more potent androgen [[dihydrotestosterone]] (DHT), in certain [[androgen-associated disorder]]s. {{TOC limit|3}} ==Medical uses== 5-ARIs are clinically used in the treatment of conditions that are exacerbated by DHT:<ref name="Rossi">Rossi S (Ed.) (2004). ''[[Australian Medicines Handbook]] 2004''. Adelaide: Australian Medicines Handbook. {{ISBN|0-9578521-4-2}}</ref> * Mild-to-moderate [[benign prostatic hyperplasia]] and [[lower urinary tract symptoms]] * [[Pattern hair loss]] in both men and women 5-ARIs can be used in the treatment of [[hirsutism]] in women.<ref name="Blume-PeytaviWhiting2008" /> The usefulness of 5-ARIs for the potential treatment of [[acne]] is uncertain.<ref name="pmid22235201" /> 5-ARIs are sometimes used as antiandrogens in [[feminizing hormone therapy]] for [[transgender women]] to help reduce body hair growth and scalp hair loss.<ref name="pmid28159148" /> They have also been explored in the treatment and prevention of [[prostate cancer]]. While the 5-ARI [[finasteride]] reduces the cancer risk by about a third, it also increases the fraction of aggressive forms of prostate cancer. Overall, there does not seem to be a survival benefit for prostate cancer patients under finasteride.<ref>{{Cite journal|last1=Thompson|first1=Ian M. Jr.|last2=Goodman|first2=Phyllis J.|last3=Tangen|first3=Catherine M.|last4=Parnes|first4=Howard L.|last5=Minasian|first5=Lori M.|last6=Godley|first6=Paul A.|last7=Lucia|first7=M. Scott|last8=Ford|first8=Leslie G.|date=2013-08-15|title=Long-Term Survival of Participants in the Prostate Cancer Prevention Trial|journal=New England Journal of Medicine|volume=369|issue=7|pages=603–610|doi=10.1056/NEJMoa1215932|issn=0028-4793| pmc=4141537 |pmid=23944298}}</ref> ===Available forms=== [[Finasteride]] (brand names Proscar, Propecia) inhibits the function of two of the isoenzymes (types 2 and 3) of 5α-reductase.<ref name="Yamana_2010">{{cite journal | vauthors = Yamana K, Labrie F, Luu-The V | title = Human type 3 5α-reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited by finasteride and dutasteride | journal = Hormone Molecular Biology and Clinical Investigation |date=January 2010 | volume = 2 | issue = 3 | pages = 293–9 | doi = 10.1515/hmbci.2010.035 | pmid = 25961201 | s2cid = 28841145 }}</ref><ref>{{cite journal |author1=Yamana K. |author2=Labrie F. |author3=Luu-The V. | year = 2010 | title = Human type 3 5α- reductase is expressed in peripheral tissues at higher levels than types 1 and 2 and its activity is potently inhibited finasteride and dutasteride | journal = Hormone Molecular Biology and Clinical Investigation | volume = 2 | issue = 3| pages = 293–299 | doi=10.1515/hmbci.2010.035|pmid=25961201 |s2cid=28841145 |display-authors=etal}}</ref> It decreases circulating DHT levels by up to about 70%.<ref>{{cite journal |author1=McConnell J. D. |author2=Wilson J. D. |author3=George F. W. |author4=Geller J. |author5=Pappas F. |author6=Stoner E. | year = 1992 | title = Finasteride, an inhibitor of 5α-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia | journal = Journal of Clinical Endocrinology and Metabolism | volume = 74 | issue = 3| pages = 505–508 |doi=10.1210/jcem.74.3.1371291 | pmid=1371291}}</ref> [[Dutasteride]] (brand name Avodart) inhibits all three 5α-reductase isoenzymes and can decrease DHT levels by 95%.<ref>{{cite journal |author1=Clark R. V. |author2=Hermann D. J. |author3=Cunningham G. R. |author4=Wilson T. H. |author5=Morrill B. B. |author6=Hobbs S. | year = 2004 | title = Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5α-reductase inhibitor | journal = Journal of Clinical Endocrinology and Metabolism | volume = 89 | issue = 5| pages = 2179–2184 | doi=10.1210/jc.2003-030330 | pmid=15126539}}</ref><ref>{{cite journal | author = Moss G. P. | year = 1989 | title = Nomenclature of steroids (Recommendations 1989) | journal = Pure and Applied Chemistry | volume = 61 | issue = 10| pages = 1783–1822 | doi=10.1351/pac198961101783| s2cid = 97612891 | doi-access = free }}</ref> It can also reduce DHT levels in the prostate by 97 to 99% in men with prostate cancer.<ref>G. L. Andriole, P. Humphrey, P. Ray et al., "Effect of the dual 5α-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer,"</ref><ref>{{cite journal |author1=Gleave M. |author2=Qian J. |author3=Andreou C. | year = 2006 | title = The effects of the dual 5α-reductase inhibitor dutasteride on localized prostate cancer—results from a 4-month pre-radical prostatectomy study | journal = The Prostate | volume = 66 | issue = 15| pages = 1674–1685 | doi=10.1002/pros.20499|display-authors=etal | pmid=16927304|s2cid=40446842 | doi-access=free }}</ref> [[Epristeride]] (brand names Aipuliete, Chuanliu) is marketed in [[China]] for the treatment of benign prostatic hyperplasia.<ref name="MortonHall1999-Epristeride">{{cite book|author1=I.K. Morton|author2=Judith M. Hall|title=Concise Dictionary of Pharmacological Agents: Properties and Synonyms|url=https://books.google.com/books?id=mqaOMOtk61IC&pg=PA113|date=31 October 1999|publisher=Springer Science & Business Media|isbn=978-0-7514-0499-9|pages=113–|access-date=4 June 2017|archive-date=24 February 2024|archive-url=https://web.archive.org/web/20240224185652/https://books.google.com/books?id=mqaOMOtk61IC&pg=PA113#v=onepage&q&f=false|url-status=live}}</ref><ref name="AdisInsight-Epristeride">{{Cite web|url=http://adisinsight.springer.com/drugs/800002533|title=Epristeride - AdisInsight|access-date=2017-06-04|archive-date=2016-11-08|archive-url=https://web.archive.org/web/20161108135117/http://adisinsight.springer.com/drugs/800002533|url-status=live}}</ref><ref name="Drugs.com-Epristeride">{{Cite web|url=https://www.drugs.com/international/epristeride.html|title=List of 21 Benign Prostatic Hyperplasia Medications Compared|access-date=2017-06-04|archive-date=2017-12-11|archive-url=https://web.archive.org/web/20171211105106/https://www.drugs.com/international/epristeride.html|url-status=live}}</ref> However, it can only decrease circulating DHT levels by about 25 to 54%.<ref name="Publishers1996">{{cite book|author=Bentham Science Publishers|title=Current Pharmaceutical Design|url=https://books.google.com/books?id=IYn4Va7wtAoC&pg=PA70|date=February 1996|publisher=Bentham Science Publishers|pages=70–}}</ref> [[Alfatradiol]] (brand names Ell-Cranell Alpha, Pantostin) is a topical 5-ARI used to treat pattern hair loss in [[Europe]].<ref name="Hunnius">{{cite book|editor1-first=Artur|editor1-last=Berger|editor2-first=Helmut|editor2-last=Wachter|title=Hunnius Pharmazeutisches Wörterbuch|edition=8th|publisher=Walter de Gruyter Verlag|year=1998|language=de|page=486|isbn=978-3-11-015793-2}}</ref><ref name="Mutschler">{{cite book|last=Mutschler|first=Ernst|author2=Gerd Geisslinger|author3=Heyo K. Kroemer|author4=Monika Schäfer-Korting|title=Arzneimittelwirkungen|publisher=Wissenschaftliche Verlagsgesellschaft|location=Stuttgart|year=2001|edition=8th|page=453|isbn=978-3-8047-1763-3|language=de}}</ref> {{5α-Reductase inhibitors marketed for clinical or veterinary use}} ==Side effects== 5-ARIs are generally [[drug tolerability|well tolerated]] in both men and women and produce few [[side effect]]s.<ref name="pmid27672412">{{cite journal | vauthors = Hirshburg JM, Kelsey PA, Therrien CA, Gavino AC, Reichenberg JS | title = Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review | journal = J Clin Aesthet Dermatol | volume = 9 | issue = 7 | pages = 56–62 | year = 2016 | pmid = 27672412 | pmc = 5023004 }}</ref><ref name="pmid27784557">{{cite journal | vauthors = Trost L, Saitz TR, Hellstrom WJ | title = Side Effects of 5-Alpha Reductase Inhibitors: A Comprehensive Review | journal = Sex Med Rev | volume = 1 | issue = 1 | pages = 24–41 | year = 2013 | pmid = 27784557 | doi = 10.1002/smrj.3 }}</ref> However, they have been found to have some risks in studies with men, including slightly increased risks of decreased [[libido]], [[erectile dysfunction]], [[ejaculatory dysfunction (disambiguation)|ejaculatory dysfunction]]<!--the ambiguity is in the source-->, [[infertility]], [[breast tenderness]], [[gynecomastia]], [[depression (mood)|depression]], [[anxiety]], [[self-harm]], and [[dementia]].<ref name="pmid27784557" /><ref name="pmid28319231">{{cite journal | vauthors = Welk B, McArthur E, Ordon M, Anderson KK, Hayward J, Dixon S | title = Association of Suicidality and Depression With 5α-Reductase Inhibitors | journal = JAMA Intern Med | volume = 177 | issue = 5 | pages = 683–691 | year = 2017 | pmid = 28319231 | pmc = 5818776 | doi = 10.1001/jamainternmed.2017.0089 }}</ref><ref name="WelkMcArthur2017">{{cite journal|last1=Welk|first1=Blayne|last2=McArthur|first2=Eric|last3=Ordon|first3=Michael|last4=Morrow|first4=Sarah A.|last5=Hayward|first5=Jade|last6=Dixon|first6=Stephanie|title=The risk of dementia with the use of 5 alpha reductase inhibitors|journal=Journal of the Neurological Sciences|volume=379|year=2017|pages=109–111|issn=0022-510X|doi=10.1016/j.jns.2017.05.064|pmid=28716218|s2cid=4765640}}</ref> In addition, although 5-ARIs decrease the overall risk of developing [[prostate cancer]], they have been found to increase the risk of developing certain rare but high-grade forms of prostate cancer.<ref name="pmid27672412" /> As a result, the FDA has notified healthcare professionals that the Warnings and Precautions section of the labels for the 5-ARI class of drugs has been revised to include new safety information about the increased risk of being diagnosed with these rare but more serious forms of prostate cancer.<ref name="Drugs.com-Label">{{cite web |url=https://www.drugs.com/fda/5-alpha-reductase-inhibitors-5-aris-label-change-increased-risk-prostate-cancer-12977.html |title=FDA Alert: 5-alpha reductase inhibitors (5-ARIs): Label Change – Increased Risk of Prostate Cancer |publisher=Drugs.com |access-date=2014-06-08 |archive-date=2014-07-14 |archive-url=https://web.archive.org/web/20140714153526/http://www.drugs.com/fda/5-alpha-reductase-inhibitors-5-aris-label-change-increased-risk-prostate-cancer-12977.html |url-status=live }}</ref> Finasteride has also been associated with [[intraoperative floppy iris syndrome]] and [[cataract]] formation.<ref name="pmid21555201">{{Cite journal | last1 = Wong | first1 = A. C. M. | last2 = Mak | first2 = S. T. | doi = 10.1016/j.jcrs.2011.04.013 | title = Finasteride-associated cataract and intraoperative floppy-iris syndrome | journal = Journal of Cataract & Refractive Surgery | volume = 37 | issue = 7 | pages = 1351–1354 | year = 2011 | pmid = 21555201 }}</ref><ref name="pmid18053919">{{Cite journal | last1 = Issa | first1 = S. A. | last2 = Dagres | first2 = E. | doi = 10.1016/j.jcrs.2007.07.025 | title = Intraoperative floppy-iris syndrome and finasteride intake | journal = Journal of Cataract & Refractive Surgery | volume = 33 | issue = 12 | pages = 2142–2143 | year = 2007 | pmid = 18053919 }}</ref> Depressive symptoms and suicidality have been reported.<ref name="pmid28456011">{{cite journal | vauthors = Locci A, Pinna G | title = Neurosteroid biosynthesis downregulation and changes in GABAA receptor subunit composition: A biomarker axis in stress-induced cognitive and emotional impairment | journal = Br. J. Pharmacol. | volume = 174| issue = 19| pages = 3226–3241| year = 2017 | pmid = 28456011 | doi = 10.1111/bph.13843 | pmc=5595768}}</ref> ===Sexual dysfunction=== [[Sexual dysfunction]], including [[erectile dysfunction]], [[loss of libido]], and [[hypospermia|reduced ejaculate]], may occur in 3.4 to 15.8% of men treated with finasteride or dutasteride.<ref name="pmid27672412" /><ref name="pmid27475241">{{cite journal|last1=Liu|first1=L|last2=Zhao|first2=S|last3=Li|first3=F|last4=Li|first4=E|last5=Kang|first5=R|last6=Luo|first6=L|last7=Luo|first7=J|last8=Wan|first8=S|last9=Zhao|first9=Z|title=Effect of 5α-Reductase Inhibitors on Sexual Function: A Meta-Analysis and Systematic Review of Randomized Controlled Trials.|journal=The Journal of Sexual Medicine|date=September 2016|volume=13|issue=9|pages=1297–310|doi=10.1016/j.jsxm.2016.07.006|pmid=27475241}}</ref> This is linked to lower [[quality of life]] and can cause stress in relationships.<ref name=Gur2013>{{cite journal|last=Gur|first=S|author2=Kadowitz, PJ |author3=Hellstrom, WJ |title=Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation.|journal=Expert Opinion on Drug Safety|date=January 2013|volume=12|issue=1|pages=81–90|pmid=23173718|doi=10.1517/14740338.2013.742885|s2cid=11624116}}</ref> There is also an association with lowered sexual desire.<ref name=Tra2011>{{cite journal|last=Traish|first=AM|author2=Hassani, J |author3=Guay, AT |author4=Zitzmann, M |author5= Hansen, ML |title=Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients.|journal=The Journal of Sexual Medicine|date=March 2011|volume=8|issue=3|pages=872–84|pmid=21176115|doi=10.1111/j.1743-6109.2010.02157.x}}</ref> It has been reported that in a subset of men, these adverse sexual side effects may persist even after discontinuation of finasteride or dutasteride.<ref name=Tra2011/> ===Breast changes=== 5-ARIs have a small risk of [[breast]] changes in men including [[breast tenderness]] and [[gynecomastia]] (breast development/enlargement).<ref name="pmid27784557" /> The risk of gynecomastia is about 1.3%.<ref name="pmid27784557" /> There is no association of 5-ARIs with [[male breast cancer]].<ref name="pmid27784557" /><ref name="pmid29697934">{{cite journal | vauthors = Wang J, Zhao S, Luo L, Li E, Li X, Zhao Z | title = 5-alpha Reductase Inhibitors and risk of male breast cancer: a systematic review and meta-analysis | journal = Int Braz J Urol | volume = 44 | issue = 5 | pages = 865–873 | date = 2018 | pmid = 29697934 | pmc = 6237523 | doi = 10.1590/S1677-5538.IBJU.2017.0531 }}</ref> ===Emotional changes=== A 2017 [[population study|population-based]], [[matching (statistics)|matched]]-[[cohort study]] of 93,197 men aged 66&nbsp;years and older with BPH found that finasteride and dutasteride were associated with a significantly increased risk of depression ({{abbrlink|HR|Hazard ratio}}, 1.94; 95% {{abbrlink|CI|Confidence interval}}, 1.73–2.16) and [[self-harm]] (HR, 1.88; 95% CI, 1.34–2.64) during the first 18&nbsp;months of treatment, but were not associated with an increased risk of [[suicide]] (HR, 0.88; 95% CI, 0.53–1.45).<ref name="pmid29528971">{{cite journal | vauthors = Lee JY, Cho KS | title = Effects of 5-alpha reductase inhibitors: new insights on benefits and harms | journal = Curr Opin Urol | volume = 28 | issue = 3 | pages = 288–293 | date = May 2018 | pmid = 29528971 | doi = 10.1097/MOU.0000000000000497 | s2cid = 4587434 }}</ref><ref name="Traish2018">{{cite journal|last1=Traish|first1=Abdulmaged M.|title=The Post-finasteride Syndrome: Clinical Manifestation of Drug-Induced Epigenetics Due to Endocrine Disruption|journal=Current Sexual Health Reports|volume=10|issue=3|year=2018|pages=88–103|issn=1548-3584|doi=10.1007/s11930-018-0161-6|s2cid=81560714}}</ref><ref name="pmid30651009">{{cite journal | vauthors = Maksym RB, Kajdy A, Rabijewski M | title = Post-finasteride syndrome - does it really exist? | journal = Aging Male | volume = 22| issue = 4| pages = 250–259 | date = January 2019 | pmid = 30651009 | doi = 10.1080/13685538.2018.1548589 | s2cid = 58569946 | doi-access = free }}</ref><ref name="pmid28319231" /> After the initial 18&nbsp;months of therapy, the risk of self-harm was no longer heightened, whereas the elevation in risk of depression lessened but remained marginally increased (HR, 1.22; 95% CI, 1.08–1.37).<ref name="pmid29528971" /><ref name="Traish2018" /><ref name="pmid28319231" /> The absolute increase in the rate of depression was 247 per 100,000 patient-years and of self-harm was 17 per 100,000 patient-years.<ref name="pmid28319231" /><ref name="pmid28319227">{{cite journal | vauthors = Thielke S | title = The Risk of Suicidality and Depression From 5-α Reductase Inhibitors | journal = JAMA Intern Med | volume = 177 | issue = 5 | pages = 691–692 | year = 2017 | pmid = 28319227 | doi = 10.1001/jamainternmed.2017.0096 }}</ref> As such, on the basis of these findings, it has been stated that cases of depression in patients that are attributable to 5-ARIs will be encountered on occasion, while cases of self-harm attributable to 5-ARIs will be encountered very rarely.<ref name="pmid28319227" /> There were no differences in the rates of depression, self-harm, and suicide between finasteride and dutasteride, suggesting that the specific 5-ARI used does not influence the risks.<ref name="pmid30651009" /><ref name="pmid28319231" /><ref name="pmid28319227" /> The absolute risks of self-harm and depression with 5-ARIs remain low (0.14% and 2.0%, respectively).<ref name="pmid29449167">{{cite journal | vauthors = Malde S, Cartwright R, Tikkinen KA | title = What's New in Epidemiology? | journal = Eur Urol Focus | volume = 4 | issue = 1 | pages = 11–13 | date = January 2018 | pmid = 29449167 | doi = 10.1016/j.euf.2018.02.003 }}</ref> ==Pharmacology== The pharmacology of 5α-reductase inhibition is complex, but involves the binding of [[NADPH]] to the enzyme followed by the substrate. Specific substrates include [[testosterone]], [[progesterone]], [[androstenedione]], [[epitestosterone]], [[cortisol]], [[aldosterone]], and [[deoxycorticosterone]]. The entire physiologic effect of their reduction is unknown, but likely related to their excretion or is itself physiologic.<ref name="pmid22235201" /> 5α-Reductase reduces the steroid Δ<sup>4,5</sup> double bond in testosterone to its more active form DHT. Thus, inhibition results in decreased amounts of DHT. Because of this, slight elevations in testosterone and estradiol levels occur.<ref name=":1">{{Cite journal|last=Andersson|first=S.|date=July 2001|title=Steroidogenic enzymes in skin|journal=European Journal of Dermatology|volume=11|issue=4|pages=293–295|issn=1167-1122|pmid=11399532}}</ref> The 5α-reductase reaction is a rate-limiting step in the testosterone reduction and involves the binding of [[NADPH]] to the enzyme followed by the substrate.<ref name="pmid22235201">{{cite journal|display-authors=etal|year=2012|title=The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseases|journal=Adv. Urol.|volume=2012|page=530121|doi=10.1155/2012/530121|pmc=3253436|pmid=22235201|vauthors=Azzouni F, Godoy A, Li Y, Mohler J|doi-access=free}}</ref><ref name="pmid16834758">{{Cite journal|last1=Finn|first1=Deborah A.|last2=Beadles-Bohling|first2=Amy S.|last3=Beckley|first3=Ethan H.|last4=Ford|first4=Matthew M.|last5=Gililland|first5=Katherine R.|last6=Gorin-Meyer|first6=Rebecca E.|last7=Wiren|first7=Kristine M.|date=2006|title=A new look at the 5alpha-reductase inhibitor finasteride|journal=CNS Drug Reviews|volume=12|issue=1|pages=53–76|doi=10.1111/j.1527-3458.2006.00053.x|issn=1080-563X|pmid=16834758|pmc=6741762}}</ref> ::: ''Substrate + NADPH + H<sup>+</sup> → 5α-substrate + NADP<sup>+</sup>'' Beyond being a catalyst in the [[rate-limiting step]] in testosterone reduction, 5α-reductase isoforms I and II reduce progesterone to [[5α-dihydroprogesterone]] (5α-DHP) and deoxycorticosterone to [[dihydrodeoxycorticosterone]] (DHDOC). In vitro and animal models suggest subsequent 3α-reduction of DHT, 5α-DHP and DHDOC lead to neurosteroid metabolites with effect on cerebral function. These [[neurosteroid]]s, which include [[allopregnanolone]], [[tetrahydrodeoxycorticosterone]] (THDOC), and [[3α-androstanediol]], act as potent [[positive allosteric modulator]]s of [[GABAA receptor|GABA<sub>A</sub> receptors]], and have [[antidepressant]], [[anxiolytic]], [[aphrodisiac|prosexual]], and [[anticonvulsant]] effects.<ref>{{Cite journal | last1 = Finn | first1 = D. A. | last2 = Beadles-Bohling | first2 = A. S. | last3 = Beckley | first3 = E. H. | last4 = Ford | first4 = M. M. | last5 = Gililland | first5 = K. R. | last6 = Gorin-Meyer | first6 = R. E. | last7 = Wiren | first7 = K. M. | doi = 10.1111/j.1527-3458.2006.00053.x | title = A New Look at the 5?-Reductase Inhibitor Finasteride | journal = CNS Drug Reviews | volume = 12 | issue = 1 | pages = 53–76 | year = 2006 | pmid = 16834758 | pmc = 6741762}}</ref> [[5α-Dihydrocortisol]] is present in the [[aqueous humor]] of the eye, is synthesized in the [[Lens (anatomy)|lens]], and might help make the aqueous humor itself.<ref name="Cort">{{cite journal | vauthors = Weinstein BI, Kandalaft N, Ritch R, Camras CB, Morris DJ, Latif SA, Vecsei P, Vittek J, Gordon GG, Southren AL | title = 5 alpha-dihydrocortisol in human aqueous humor and metabolism of cortisol by human lenses in vitro | journal = Invest. Ophthalmol. Vis. Sci. | volume = 32 | issue = 7 | pages = 2130–5 |date=June 1991 | pmid = 2055703 }}</ref> [[5α-Dihydroaldosterone]] is a potent [[antidiuretic|antinatriuretic]] agent, although different from [[aldosterone]]. Its formation in the kidney is enhanced by restriction of dietary salt, suggesting it may help retain sodium.<ref name="Kenyon_1983">{{cite journal | vauthors = Kenyon CJ, Brem AS, McDermott MJ, Deconti GA, Latif SA, Morris DJ | title = Antinatriuretic and kaliuretic activities of the reduced derivatives of aldosterone | journal = Endocrinology | volume = 112 | issue = 5 | pages = 1852–6 |date=May 1983 | pmid = 6403339 | doi =10.1210/endo-112-5-1852 }}</ref> 5α-DHP is a major hormone in circulation of normal cycling and pregnant women.<ref name="pmid914969">{{cite journal | vauthors = Milewich L, Gomez-Sanchez C, Crowley G, Porter JC, Madden JD, MacDonald PC | title = Progesterone and 5alpha-pregnane-3,20-dione in peripheral blood of normal young women: Daily measurements throughout the menstrual cycle | journal = J. Clin. Endocrinol. Metab. | volume = 45 | issue = 4 | pages = 617–22 |date=October 1977 | pmid = 914969 | doi =10.1210/jcem-45-4-617 | doi-access = free }}</ref> Other enzymes compensate to a degree for the absent conversion of 5α-reductase, specifically with local expression at the skin of reductive [[17β-hydroxysteroid dehydrogenase]], and oxidative [[3α-hydroxysteroid dehydrogenase]] and [[3β-hydroxysteroid dehydrogenase]] enzymes.<ref>{{Cite journal | last1 = Andersson | first1 = S. | title = Steroidogenic enzymes in skin | journal = European Journal of Dermatology | volume = 11 | issue = 4 | pages = 293–295 | year = 2001 | pmid = 11399532}}</ref> In BPH, DHT acts as a potent cellular androgen and promotes [[prostate]] growth; therefore, DHT blockers inhibit and alleviate symptoms of BPH. In alopecia, male and female-pattern baldness is an effect of androgenic receptor activation, so reducing levels of DHT also reduces hair loss. ==History== Finasteride was the first 5-ARI to be introduced for medical use.<ref name="BurgerAbraham2003">{{cite book|author1=Alfred Burger|author2=Donald J. Abraham|title=Burger's Medicinal Chemistry and Drug Discovery, Autocoids, Diagnostics, and Drugs from New Biology|url=https://books.google.com/books?id=25ZUAAAAMAAJ|date=20 February 2003|publisher=Wiley|isbn=978-0-471-37030-7|page=439|access-date=24 December 2017|archive-date=10 January 2023|archive-url=https://web.archive.org/web/20230110031744/https://books.google.com/books?id=25ZUAAAAMAAJ|url-status=live}}</ref> It was marketed for the treatment of BPH in 1992 and was subsequently approved for the treatment of pattern hair loss in 1997.<ref name="BurgerAbraham2003" /> Epristeride was the second 5-ARI to be introduced and was marketed for the treatment of BPH in [[China]] in 2000.<ref name="AdisInsight-Epristeride" /> Dutasteride was approved for the treatment of BPH in 2001 and was subsequently approved for pattern hair loss in [[South Korea]] in 2009 and in [[Japan]] in 2015.<ref name="Llewellyn2011">{{cite book|author=William Llewellyn|title=Anabolics|url=https://books.google.com/books?id=afKLA-6wW0oC&pg=PT971|year=2011|publisher=Molecular Nutrition Llc|isbn=978-0-9828280-1-4|pages=968–,971–|access-date=2017-12-24|archive-date=2023-01-12|archive-url=https://web.archive.org/web/20230112145743/https://books.google.com/books?id=afKLA-6wW0oC&pg=PT971|url-status=live}}</ref><ref name="MacDonald">{{cite web|last1=MacDonald|first1=Gareth|title=GSK Japan delays alopecia drug launch after Catalent manufacturing halt|date=3 December 2015|url=http://www.in-pharmatechnologist.com/Regulatory-Safety/GSK-Japan-delays-alopecia-drug-launch-after-Catalent-manufacturing-halt|access-date=24 December 2017|archive-date=1 October 2016|archive-url=https://web.archive.org/web/20161001165059/http://www.in-pharmatechnologist.com/Regulatory-Safety/GSK-Japan-delays-alopecia-drug-launch-after-Catalent-manufacturing-halt|url-status=live}}</ref> The [[patent protection]] on finasteride and dutasteride has expired and both drugs are available as [[generic drug|generic medication]]s.<ref name="SataloffSclafani2015">{{cite book|author1=Robert T Sataloff|author2=Anthony P Sclafani|title=Sataloff's Comprehensive Textbook of Otolaryngology: Head & Neck Surgery: Facial Plastic and Reconstructive Surgery|url=https://books.google.com/books?id=acswCwAAQBAJ&pg=PA400|date=30 November 2015|publisher=JP Medical Ltd|isbn=978-93-5152-459-5|pages=400–|access-date=24 December 2017|archive-date=10 January 2023|archive-url=https://web.archive.org/web/20230110031702/https://books.google.com/books?id=acswCwAAQBAJ&pg=PA400|url-status=live}}</ref><ref name="Drugs.com-Dutasteride">{{Cite web|url=https://www.drugs.com/availability/generic-avodart.html|title=Generic Avodart Availability|access-date=2017-12-24|archive-date=2016-12-20|archive-url=https://web.archive.org/web/20161220231141/https://www.drugs.com/availability/generic-avodart.html|url-status=live}}</ref> ==Research== 5-ARIs have been studied in combination with the [[nonsteroidal antiandrogen]] [[bicalutamide]] for the treatment of prostate cancer.<ref name="pmid15138573">{{cite journal |vauthors=Wang LG, Mencher SK, McCarron JP, Ferrari AC |title=The biological basis for the use of an anti-androgen and a 5-alpha-reductase inhibitor in the treatment of recurrent prostate cancer: Case report and review |journal=Oncology Reports |volume=11 |issue=6 |pages=1325–9 |year=2004 |pmid=15138573 |doi= 10.3892/or.11.6.1325}}</ref><ref name="pmid15151957">{{cite journal |vauthors=Tay MH, Kaufman DS, Regan MM, Leibowitz SB, George DJ, Febbo PG, Manola J, Smith MR, Kaplan ID, Kantoff PW, Oh WK |title=Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostate |journal=Annals of Oncology |volume=15 |issue=6 |pages=974–8 |year=2004 |pmid=15151957 |doi=10.1093/annonc/mdh221 |doi-access=free }}</ref><ref name="pmid16844453">{{cite journal |vauthors=Merrick GS, Butler WM, Wallner KE, Galbreath RW, Allen ZA, Kurko B |title=Efficacy of neoadjuvant bicalutamide and dutasteride as a cytoreductive regimen before prostate brachytherapy |journal=Urology |volume=68 |issue=1 |pages=116–20 |year=2006 |pmid=16844453 |doi=10.1016/j.urology.2006.01.061 }}</ref><ref name="pmid19796455">{{cite journal |vauthors=Sartor O, Gomella LG, Gagnier P, Melich K, Dann R |title=Dutasteride and bicalutamide in patients with hormone-refractory prostate cancer: the Therapy Assessed by Rising PSA (TARP) study rationale and design |journal=The Canadian Journal of Urology |volume=16 |issue=5 |pages=4806–12 |year=2009 |pmid=19796455 }}</ref><ref name="pmid26048455">{{cite journal |vauthors=Chu FM, Sartor O, Gomella L, Rudo T, Somerville MC, Hereghty B, Manyak MJ |title=A randomised, double-blind study comparing the addition of bicalutamide with or without dutasteride to GnRH analogue therapy in men with non-metastatic castrate-resistant prostate cancer |journal=European Journal of Cancer |volume=51 |issue=12 |pages=1555–69 |year=2015 |pmid=26048455 |doi=10.1016/j.ejca.2015.04.028 }}</ref><ref name="pmid26702991">{{cite journal |vauthors=Gaudet M, Vigneault É, Foster W, Meyer F, Martin AG |title=Randomized non-inferiority trial of Bicalutamide and Dutasteride versus LHRH agonists for prostate volume reduction prior to I-125 permanent implant brachytherapy for prostate cancer |journal=Radiotherapy and Oncology |volume=118 |issue=1 |pages=141–7 |year=2016 |pmid=26702991 |doi=10.1016/j.radonc.2015.11.022 }}</ref><ref name="pmid27330919">{{cite journal |vauthors=Dijkstra S, Witjes WP, Roos EP, Vijverberg PL, Geboers AD, Bruins JL, Smits GA, Vergunst H, Mulders PF |title=The AVOCAT study: Bicalutamide monotherapy versus combined bicalutamide plus dutasteride therapy for patients with locally advanced or metastatic carcinoma of the prostate-a long-term follow-up comparison and quality of life analysis |journal=SpringerPlus |volume=5 |pages=653 |year=2016 |pmid=27330919 |pmc=4870485 |doi=10.1186/s40064-016-2280-8 |doi-access=free }}</ref> ==See also== * [[List of 5α-reductase inhibitors]] * [[Discovery and development of 5α-reductase inhibitors]] * [[CYP17A1 inhibitor]] * [[Neurosteroidogenesis inhibitor]] ==References== {{Reflist|30em}} {{Enzyme inhibition}} {{Drugs used in benign prostatic hypertrophy}} {{Other dermatological preparations}} {{Androgens and antiandrogens}} [[Category:5α-Reductase inhibitors| ]] [[Category:Hair loss medications]] [[Category:Hair removal]] [[Category:Antiandrogens]] </textarea><div class="templatesUsed"><div class="mw-templatesUsedExplanation"><p><span id="templatesused">Pages transcluded onto the current version of this page<span class="posteditwindowhelplinks"> (<a href="/wiki/Help:Transclusion" title="Help:Transclusion">help</a>)</span>:</span> </p></div><ul> <li><a href="/wiki/Template:5%CE%B1-Reductase_inhibitors_marketed_for_clinical_or_veterinary_use" title="Template:5α-Reductase inhibitors marketed for clinical or veterinary use">Template:5α-Reductase inhibitors marketed for clinical or veterinary use</a> (<a href="/w/index.php?title=Template:5%CE%B1-Reductase_inhibitors_marketed_for_clinical_or_veterinary_use&action=edit" title="Template:5α-Reductase inhibitors marketed for clinical or veterinary use">edit</a>) </li><li><a href="/wiki/Template:Abbr" title="Template:Abbr">Template:Abbr</a> (<a href="/w/index.php?title=Template:Abbr&action=edit" title="Template:Abbr">view source</a>) (protected)</li><li><a href="/wiki/Template:Abbrlink" title="Template:Abbrlink">Template:Abbrlink</a> (<a href="/w/index.php?title=Template:Abbrlink&action=edit" title="Template:Abbrlink">view source</a>) (template editor protected)</li><li><a href="/wiki/Template:Androgens_and_antiandrogens" title="Template:Androgens and antiandrogens">Template:Androgens and antiandrogens</a> (<a href="/w/index.php?title=Template:Androgens_and_antiandrogens&action=edit" title="Template:Androgens and antiandrogens">view source</a>) (semi-protected)</li><li><a href="/wiki/Template:Catalog_lookup_link" title="Template:Catalog lookup link">Template:Catalog lookup link</a> (<a href="/w/index.php?title=Template:Catalog_lookup_link&action=edit" title="Template:Catalog lookup link">view source</a>) (template editor protected)</li><li><a href="/wiki/Template:Cite_book" title="Template:Cite book">Template:Cite book</a> (<a href="/w/index.php?title=Template:Cite_book&action=edit" title="Template:Cite book">view source</a>) (protected)</li><li><a href="/wiki/Template:Cite_journal" title="Template:Cite journal">Template:Cite journal</a> (<a href="/w/index.php?title=Template:Cite_journal&action=edit" title="Template:Cite journal">view source</a>) (protected)</li><li><a href="/wiki/Template:Cite_web" title="Template:Cite web">Template:Cite web</a> (<a href="/w/index.php?title=Template:Cite_web&action=edit" title="Template:Cite web">view source</a>) (protected)</li><li><a href="/wiki/Template:Drugs_used_in_benign_prostatic_hypertrophy" title="Template:Drugs used in benign prostatic hypertrophy">Template:Drugs used in benign prostatic hypertrophy</a> (<a href="/w/index.php?title=Template:Drugs_used_in_benign_prostatic_hypertrophy&action=edit" title="Template:Drugs used in benign prostatic hypertrophy">edit</a>) </li><li><a href="/wiki/Template:Enzyme_inhibition" title="Template:Enzyme inhibition">Template:Enzyme inhibition</a> (<a href="/w/index.php?title=Template:Enzyme_inhibition&action=edit" title="Template:Enzyme inhibition">edit</a>) </li><li><a href="/wiki/Template:Flatlist" title="Template:Flatlist">Template:Flatlist</a> (<a href="/w/index.php?title=Template:Flatlist&action=edit" title="Template:Flatlist">view source</a>) (protected)</li><li><a href="/wiki/Template:Hlist/styles.css" title="Template:Hlist/styles.css">Template:Hlist/styles.css</a> (<a href="/w/index.php?title=Template:Hlist/styles.css&action=edit" title="Template:Hlist/styles.css">view source</a>) (protected)</li><li><a href="/wiki/Template:ISBN" title="Template:ISBN">Template:ISBN</a> (<a href="/w/index.php?title=Template:ISBN&action=edit" title="Template:ISBN">view source</a>) (template editor protected)</li><li><a href="/wiki/Template:Infobox" title="Template:Infobox">Template:Infobox</a> (<a href="/w/index.php?title=Template:Infobox&action=edit" title="Template:Infobox">view source</a>) (template editor protected)</li><li><a href="/wiki/Template:Infobox_drug/legal_status" title="Template:Infobox drug/legal status">Template:Infobox drug/legal status</a> (<a href="/w/index.php?title=Template:Infobox_drug/legal_status&action=edit" title="Template:Infobox drug/legal status">view source</a>) (template editor protected)</li><li><a href="/wiki/Template:Infobox_drug_class" title="Template:Infobox drug class">Template:Infobox drug class</a> (<a href="/w/index.php?title=Template:Infobox_drug_class&action=edit" title="Template:Infobox drug class">edit</a>) </li><li><a href="/wiki/Template:Main_other" title="Template:Main other">Template:Main other</a> (<a href="/w/index.php?title=Template:Main_other&action=edit" title="Template:Main other">view source</a>) (protected)</li><li><a href="/wiki/Template:Navbar" title="Template:Navbar">Template:Navbar</a> (<a href="/w/index.php?title=Template:Navbar&action=edit" title="Template:Navbar">view source</a>) (protected)</li><li><a href="/wiki/Template:Navbox" title="Template:Navbox">Template:Navbox</a> (<a href="/w/index.php?title=Template:Navbox&action=edit" title="Template:Navbox">view source</a>) (template editor protected)</li><li><a href="/wiki/Template:Other_dermatological_preparations" title="Template:Other dermatological preparations">Template:Other dermatological preparations</a> (<a href="/w/index.php?title=Template:Other_dermatological_preparations&action=edit" title="Template:Other dermatological preparations">edit</a>) </li><li><a href="/wiki/Template:Pagetype" title="Template:Pagetype">Template:Pagetype</a> (<a href="/w/index.php?title=Template:Pagetype&action=edit" title="Template:Pagetype">view source</a>) (protected)</li><li><a href="/wiki/Template:PharmNavFootnote" title="Template:PharmNavFootnote">Template:PharmNavFootnote</a> (<a href="/w/index.php?title=Template:PharmNavFootnote&action=edit" title="Template:PharmNavFootnote">view source</a>) (template editor protected)</li><li><a href="/wiki/Template:Reflist" title="Template:Reflist">Template:Reflist</a> (<a href="/w/index.php?title=Template:Reflist&action=edit" title="Template:Reflist">view source</a>) (protected)</li><li><a href="/wiki/Template:Reflist/styles.css" title="Template:Reflist/styles.css">Template:Reflist/styles.css</a> (<a href="/w/index.php?title=Template:Reflist/styles.css&action=edit" title="Template:Reflist/styles.css">view source</a>) (protected)</li><li><a href="/wiki/Template:SDcat" title="Template:SDcat">Template:SDcat</a> (<a href="/w/index.php?title=Template:SDcat&action=edit" title="Template:SDcat">view source</a>) (protected)</li><li><a href="/wiki/Template:Short_description" title="Template:Short description">Template:Short description</a> (<a href="/w/index.php?title=Template:Short_description&action=edit" title="Template:Short description">view source</a>) (protected)</li><li><a href="/wiki/Template:Short_description/lowercasecheck" title="Template:Short description/lowercasecheck">Template:Short description/lowercasecheck</a> (<a href="/w/index.php?title=Template:Short_description/lowercasecheck&action=edit" title="Template:Short description/lowercasecheck">view source</a>) (protected)</li><li><a href="/wiki/Template:TOC_limit" title="Template:TOC limit">Template:TOC limit</a> (<a href="/w/index.php?title=Template:TOC_limit&action=edit" title="Template:TOC limit">view source</a>) (template editor protected)</li><li><a href="/wiki/Template:TOC_limit/styles.css" title="Template:TOC limit/styles.css">Template:TOC limit/styles.css</a> (<a href="/w/index.php?title=Template:TOC_limit/styles.css&action=edit" title="Template:TOC limit/styles.css">view source</a>) (template editor protected)</li><li><a href="/wiki/Template:Template_other" title="Template:Template other">Template:Template other</a> (<a href="/w/index.php?title=Template:Template_other&action=edit" title="Template:Template other">view source</a>) (protected)</li><li><a href="/wiki/Template:Wikidata" title="Template:Wikidata">Template:Wikidata</a> (<a href="/w/index.php?title=Template:Wikidata&action=edit" title="Template:Wikidata">view source</a>) (template editor protected)</li><li><a href="/wiki/Template:Yesno" title="Template:Yesno">Template:Yesno</a> (<a href="/w/index.php?title=Template:Yesno&action=edit" title="Template:Yesno">view source</a>) (protected)</li><li><a href="/wiki/Template:Yesno-no" title="Template:Yesno-no">Template:Yesno-no</a> (<a href="/w/index.php?title=Template:Yesno-no&action=edit" title="Template:Yesno-no">view source</a>) (template editor protected)</li><li><a href="/wiki/Template:Yesno-yes" title="Template:Yesno-yes">Template:Yesno-yes</a> (<a href="/w/index.php?title=Template:Yesno-yes&action=edit" title="Template:Yesno-yes">view source</a>) (template editor protected)</li><li><a href="/wiki/Module:Arguments" title="Module:Arguments">Module:Arguments</a> (<a href="/w/index.php?title=Module:Arguments&action=edit" title="Module:Arguments">view source</a>) (protected)</li><li><a href="/wiki/Module:Catalog_lookup_link" title="Module:Catalog lookup link">Module:Catalog lookup link</a> (<a href="/w/index.php?title=Module:Catalog_lookup_link&action=edit" title="Module:Catalog lookup link">view source</a>) (template editor protected)</li><li><a href="/wiki/Module:Check_for_unknown_parameters" title="Module:Check for unknown parameters">Module:Check for unknown parameters</a> (<a href="/w/index.php?title=Module:Check_for_unknown_parameters&action=edit" title="Module:Check for unknown parameters">view source</a>) (protected)</li><li><a href="/wiki/Module:Check_isxn" title="Module:Check isxn">Module:Check isxn</a> (<a href="/w/index.php?title=Module:Check_isxn&action=edit" title="Module:Check isxn">view source</a>) (template editor protected)</li><li><a href="/wiki/Module:Citation/CS1" title="Module:Citation/CS1">Module:Citation/CS1</a> (<a href="/w/index.php?title=Module:Citation/CS1&action=edit" title="Module:Citation/CS1">view source</a>) (protected)</li><li><a href="/wiki/Module:Citation/CS1/COinS" title="Module:Citation/CS1/COinS">Module:Citation/CS1/COinS</a> (<a href="/w/index.php?title=Module:Citation/CS1/COinS&action=edit" title="Module:Citation/CS1/COinS">view source</a>) (protected)</li><li><a href="/wiki/Module:Citation/CS1/Configuration" title="Module:Citation/CS1/Configuration">Module:Citation/CS1/Configuration</a> (<a href="/w/index.php?title=Module:Citation/CS1/Configuration&action=edit" title="Module:Citation/CS1/Configuration">view source</a>) (protected)</li><li><a href="/wiki/Module:Citation/CS1/Date_validation" title="Module:Citation/CS1/Date validation">Module:Citation/CS1/Date validation</a> (<a href="/w/index.php?title=Module:Citation/CS1/Date_validation&action=edit" title="Module:Citation/CS1/Date validation">view source</a>) (protected)</li><li><a href="/wiki/Module:Citation/CS1/Identifiers" title="Module:Citation/CS1/Identifiers">Module:Citation/CS1/Identifiers</a> (<a href="/w/index.php?title=Module:Citation/CS1/Identifiers&action=edit" title="Module:Citation/CS1/Identifiers">view source</a>) (protected)</li><li><a href="/wiki/Module:Citation/CS1/Utilities" title="Module:Citation/CS1/Utilities">Module:Citation/CS1/Utilities</a> (<a href="/w/index.php?title=Module:Citation/CS1/Utilities&action=edit" title="Module:Citation/CS1/Utilities">view source</a>) (protected)</li><li><a href="/wiki/Module:Citation/CS1/Whitelist" title="Module:Citation/CS1/Whitelist">Module:Citation/CS1/Whitelist</a> (<a href="/w/index.php?title=Module:Citation/CS1/Whitelist&action=edit" title="Module:Citation/CS1/Whitelist">view source</a>) (protected)</li><li><a href="/wiki/Module:Citation/CS1/styles.css" title="Module:Citation/CS1/styles.css">Module:Citation/CS1/styles.css</a> (<a href="/w/index.php?title=Module:Citation/CS1/styles.css&action=edit" title="Module:Citation/CS1/styles.css">view source</a>) (protected)</li><li><a href="/wiki/Module:Disambiguation/templates" title="Module:Disambiguation/templates">Module:Disambiguation/templates</a> (<a href="/w/index.php?title=Module:Disambiguation/templates&action=edit" title="Module:Disambiguation/templates">view source</a>) (protected)</li><li><a href="/wiki/Module:Infobox" title="Module:Infobox">Module:Infobox</a> (<a href="/w/index.php?title=Module:Infobox&action=edit" title="Module:Infobox">view source</a>) (template editor protected)</li><li><a href="/wiki/Module:Infobox/styles.css" title="Module:Infobox/styles.css">Module:Infobox/styles.css</a> (<a href="/w/index.php?title=Module:Infobox/styles.css&action=edit" title="Module:Infobox/styles.css">view source</a>) (template editor protected)</li><li><a href="/wiki/Module:InfoboxImage" title="Module:InfoboxImage">Module:InfoboxImage</a> (<a href="/w/index.php?title=Module:InfoboxImage&action=edit" title="Module:InfoboxImage">view source</a>) (template editor protected)</li><li><a href="/wiki/Module:Navbar" title="Module:Navbar">Module:Navbar</a> (<a href="/w/index.php?title=Module:Navbar&action=edit" title="Module:Navbar">view source</a>) (protected)</li><li><a href="/wiki/Module:Navbar/configuration" title="Module:Navbar/configuration">Module:Navbar/configuration</a> (<a href="/w/index.php?title=Module:Navbar/configuration&action=edit" title="Module:Navbar/configuration">view source</a>) (protected)</li><li><a href="/wiki/Module:Navbar/styles.css" title="Module:Navbar/styles.css">Module:Navbar/styles.css</a> (<a href="/w/index.php?title=Module:Navbar/styles.css&action=edit" title="Module:Navbar/styles.css">view source</a>) (protected)</li><li><a href="/wiki/Module:Navbox" title="Module:Navbox">Module:Navbox</a> (<a href="/w/index.php?title=Module:Navbox&action=edit" title="Module:Navbox">view source</a>) (template editor protected)</li><li><a href="/wiki/Module:Navbox/configuration" title="Module:Navbox/configuration">Module:Navbox/configuration</a> (<a href="/w/index.php?title=Module:Navbox/configuration&action=edit" title="Module:Navbox/configuration">view source</a>) (template editor protected)</li><li><a href="/wiki/Module:Navbox/styles.css" title="Module:Navbox/styles.css">Module:Navbox/styles.css</a> (<a href="/w/index.php?title=Module:Navbox/styles.css&action=edit" title="Module:Navbox/styles.css">view source</a>) (template editor protected)</li><li><a href="/wiki/Module:Pagetype" title="Module:Pagetype">Module:Pagetype</a> (<a href="/w/index.php?title=Module:Pagetype&action=edit" title="Module:Pagetype">view source</a>) (protected)</li><li><a href="/wiki/Module:Pagetype/config" title="Module:Pagetype/config">Module:Pagetype/config</a> (<a href="/w/index.php?title=Module:Pagetype/config&action=edit" title="Module:Pagetype/config">view source</a>) (protected)</li><li><a href="/wiki/Module:Pagetype/disambiguation" class="mw-redirect" title="Module:Pagetype/disambiguation">Module:Pagetype/disambiguation</a> (<a href="/w/index.php?title=Module:Pagetype/disambiguation&action=edit" class="mw-redirect" title="Module:Pagetype/disambiguation">view source</a>) (protected)</li><li><a href="/wiki/Module:Pagetype/rfd" title="Module:Pagetype/rfd">Module:Pagetype/rfd</a> (<a href="/w/index.php?title=Module:Pagetype/rfd&action=edit" title="Module:Pagetype/rfd">view source</a>) (protected)</li><li><a href="/wiki/Module:Pagetype/setindex" title="Module:Pagetype/setindex">Module:Pagetype/setindex</a> (<a href="/w/index.php?title=Module:Pagetype/setindex&action=edit" title="Module:Pagetype/setindex">view source</a>) (protected)</li><li><a href="/wiki/Module:Pagetype/softredirect" title="Module:Pagetype/softredirect">Module:Pagetype/softredirect</a> (<a href="/w/index.php?title=Module:Pagetype/softredirect&action=edit" title="Module:Pagetype/softredirect">view source</a>) (protected)</li><li><a href="/wiki/Module:SDcat" title="Module:SDcat">Module:SDcat</a> (<a href="/w/index.php?title=Module:SDcat&action=edit" title="Module:SDcat">view source</a>) (protected)</li><li><a href="/wiki/Module:String" title="Module:String">Module:String</a> (<a href="/w/index.php?title=Module:String&action=edit" title="Module:String">view source</a>) (protected)</li><li><a href="/wiki/Module:TableTools" title="Module:TableTools">Module:TableTools</a> (<a href="/w/index.php?title=Module:TableTools&action=edit" title="Module:TableTools">view source</a>) (protected)</li><li><a href="/wiki/Module:Wd" title="Module:Wd">Module:Wd</a> (<a href="/w/index.php?title=Module:Wd&action=edit" title="Module:Wd">view source</a>) (template editor protected)</li><li><a href="/wiki/Module:Wd/i18n" title="Module:Wd/i18n">Module:Wd/i18n</a> (<a href="/w/index.php?title=Module:Wd/i18n&action=edit" title="Module:Wd/i18n">view source</a>) (template editor protected)</li><li><a href="/wiki/Module:Wikitext_Parsing" title="Module:Wikitext Parsing">Module:Wikitext Parsing</a> (<a href="/w/index.php?title=Module:Wikitext_Parsing&action=edit" title="Module:Wikitext Parsing">view source</a>) (protected)</li><li><a href="/wiki/Module:Yesno" title="Module:Yesno">Module:Yesno</a> (<a href="/w/index.php?title=Module:Yesno&action=edit" title="Module:Yesno">view source</a>) (protected)</li></ul></div><p id="mw-returnto">Return to <a href="/wiki/5%CE%B1-Reductase_inhibitor" title="5α-Reductase inhibitor">5α-Reductase inhibitor</a>.</p> <!--esi <esi:include src="/esitest-fa8a495983347898/content" /> --><noscript><img src="https://login.wikimedia.org/wiki/Special:CentralAutoLogin/start?useformat=desktop&type=1x1&usesul3=0" alt="" width="1" height="1" style="border: none; position: absolute;"></noscript> <div class="printfooter" data-nosnippet="">Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/wiki/5α-Reductase_inhibitor">https://en.wikipedia.org/wiki/5α-Reductase_inhibitor</a>"</div></div> <div id="catlinks" class="catlinks catlinks-allhidden" data-mw="interface"></div> </div> </main> </div> <div class="mw-footer-container"> <footer id="footer" class="mw-footer" > <ul id="footer-info"> </ul> <ul id="footer-places"> <li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Privacy_policy">Privacy policy</a></li> <li id="footer-places-about"><a href="/wiki/Wikipedia:About">About Wikipedia</a></li> <li id="footer-places-disclaimers"><a href="/wiki/Wikipedia:General_disclaimer">Disclaimers</a></li> <li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li> <li id="footer-places-wm-codeofconduct"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Universal_Code_of_Conduct">Code of Conduct</a></li> <li id="footer-places-developers"><a href="https://developer.wikimedia.org">Developers</a></li> <li id="footer-places-statslink"><a href="https://stats.wikimedia.org/#/en.wikipedia.org">Statistics</a></li> <li id="footer-places-cookiestatement"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Cookie_statement">Cookie statement</a></li> <li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=5%CE%B1-Reductase_inhibitor&action=edit&mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li> </ul> <ul id="footer-icons" class="noprint"> <li id="footer-copyrightico"><a href="https://wikimediafoundation.org/" class="cdx-button cdx-button--fake-button cdx-button--size-large cdx-button--fake-button--enabled"><img src="/static/images/footer/wikimedia-button.svg" width="84" height="29" alt="Wikimedia Foundation" loading="lazy"></a></li> <li id="footer-poweredbyico"><a href="https://www.mediawiki.org/" class="cdx-button cdx-button--fake-button cdx-button--size-large cdx-button--fake-button--enabled"><img src="/w/resources/assets/poweredby_mediawiki.svg" alt="Powered by MediaWiki" width="88" height="31" loading="lazy"></a></li> </ul> </footer> </div> </div> </div> <div class="vector-settings" id="p-dock-bottom"> <ul></ul> </div><script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgHostname":"mw-web.codfw.main-55db797859-d8jdj","wgBackendResponseTime":291,"wgPageParseReport":{"limitreport":{"cputime":"0.058","walltime":"0.073","ppvisitednodes":{"value":418,"limit":1000000},"postexpandincludesize":{"value":17740,"limit":2097152},"templateargumentsize":{"value":6556,"limit":2097152},"expansiondepth":{"value":9,"limit":100},"expensivefunctioncount":{"value":0,"limit":500},"unstrip-depth":{"value":0,"limit":20},"unstrip-size":{"value":469,"limit":5000000},"entityaccesscount":{"value":0,"limit":400},"timingprofile":["100.00% 51.146 1 -total"," 99.87% 51.078 2 Template:Blocked_text"," 45.84% 23.447 2 Template:Replace"," 36.67% 18.757 1 Template:Colocationwebhost"," 33.25% 17.008 1 Template:Hidden"," 13.93% 7.127 1 Template:Hidden_begin"," 13.62% 6.966 1 Template:Tlx"," 2.15% 1.101 1 Template:Hidden_end"," 1.97% 1.010 1 MediaWiki:Wikimedia-globalblocking-blockedtext-mistake"," 1.55% 0.795 1 MediaWiki:Wikimedia-globalblocking-blockedtext-mistake-email-steward"]},"scribunto":{"limitreport-timeusage":{"value":"0.010","limit":"10.000"},"limitreport-memusage":{"value":1043346,"limit":52428800}},"cachereport":{"origin":"mw-web.codfw.main-55db797859-d8jdj","timestamp":"20241218043829","ttl":2592000,"transientcontent":false}}});});</script> </body> </html>